Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33
Status:
Unknown status
Trial end date:
2021-08-20
Target enrollment:
Participant gender:
Summary
This study is a Multi-center, Open-label, single arm, Dose Escalation and Dose Extension
Phase 1 Study to Evaluate the Safety , Tolerability, Pharmacokinetics and Preliminary
Efficacy of CYH33 in Advanced Solid Tumors Patients, and to Evaluate the Safety and
Preliminary Efficacy in Advanced esophagus canver and Squamous cell carcinoma of the
esophageal junction patients